MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-08-2023
Horizon Therapeutics Public Limited Company Total Inventories 2011-2026 | HZNP
Annual Total Inventories Horizon Therapeutics Public Limited Company
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 170 M | 226 M | 75.3 M | 53.8 M | 50.8 M | 61.7 M | 175 M | 18.4 M | 16.9 M | 8.7 M | 5.24 M | 1.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 226 M | 1.2 M | 71.8 M |
Quarterly Total Inventories Horizon Therapeutics Public Limited Company
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 170 M | 164 M | 170 M | 190 M | - | 227 M | 226 M | 237 M | 259 M | 238 M | 75.3 M | 75.3 M | 75.3 M | 75.3 M | 53.8 M | 53.8 M | 53.8 M | 53.8 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 61.7 M | 61.7 M | 61.7 M | 61.7 M | 175 M | 175 M | 175 M | 175 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 259 M | 1.2 M | 76.5 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.56 | 2.13 % | $ 3.74 B |  USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |
 |
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.43 | 3.62 % | $ 368 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 327.25 | 2.42 % | $ 42.9 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.49 | 9.56 % | $ 397 M |  Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 20.4 | -0.87 % | $ 954 M | USA |
 |
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.18 | 1.21 % | $ 447 M | USA |
 |
Aytu BioScience
AYTU
|
11.4 M | $ 2.66 | 3.5 % | $ 16.7 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.61 | 5.76 % | $ 3.13 B | USA |
 |
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Avid Bioservices
CDMO
|
30.4 M | - | - | $ 789 M | USA |